Xylem (XYL) Market Capitalization (2011 - 2026)

Xylem has reported Market Capitalization for 16 years, with the latest figure at $27.6 billion in Q2 2026.

• On a quarterly basis, Market Capitalization fell 12.34% year-over-year to $27.6 billion in Q2 2026; TTM through Jun 2026 was $27.6 billion, a 12.34% decrease from a year earlier, with the FY2025 full-year figure at $33.2 billion, up 17.64% from the prior year.
• Market Capitalization was $27.6 billion for Q2 2026 at Xylem, down from $28.4 billion in the prior quarter.
• The five-year high for Market Capitalization was $35.9 billion in Q3 2025, with the low at $14.1 billion in Q2 2022.
• Average Market Capitalization over 5 years is $26.2 billion, with a median of $27.9 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Market Capitalization tumbled 34.82% in 2022, then soared 92.54% in 2023.
• Over 5 years, Market Capitalization stood at $19.9 billion in 2022, then jumped by 38.71% to $27.6 billion in 2023, then increased by 1.99% to $28.2 billion in 2024, then advanced by 17.64% to $33.2 billion in 2025, then declined by 16.79% to $27.6 billion in 2026.
• The last three Market Capitalization figures came in at $27.6 billion (Q2 2026), $28.4 billion (Q1 2026), and $33.2 billion (Q4 2025), per Business Quant data.